Welcome! Accelerate Your Discovery

Be a part of a committed society that is shaping the future of knowledge Search

Spermatogenesis in aged rats after prenatal 3,3,4,4,5-pentachlorobiphenyl exposure

Article Number: SIS028394AI180824
18th August, 2024
Author(s):
S. Wakui et al.
Abstract:

We previously reported that prenatal exposure to 3,3 ,4,4 ,5-pentachlorobiphenyl (PCB126) had dose-related adverse effects on the spermatogenesis of 7(pubescent)- and 17(adult)-week-old rats, but the effects in middle and old age have been unclear. In this study, the spermatogenesis of male Sprague–Dawley rats whose dams had been injected (i.g.) with 25 pg, 2.5 ng, 250 ng, or 7.5 g of PCB126/kg or the vehicle on days 13–19 post-conception was investigated at 52 and 90 weeks of age. At 52 weeks, the 7.5 g group showed a significant decrease of preleptotene spermatocytes in stages VII–VIII seminiferous tubules, round spermatids increased at stages VI–VII and elongated spermatids decreased at stage VIII, while the spermatogenesis of the other PCB-treated groups were similar to that of the vehicle group. At 90 weeks, the 7.5 g group showed a significant decrease of spermatogenic cells at many stages, and the 250 ng group showed a significant decrease of preleptotene spermatocytes at stages VII–VIII, and round spermatids increased at stages VI–VII, elongated spermatids decreased at stage VIII, and the spermatogenesis of the 2.5 ng and 25 pg groups were similar to those of the vehicle group. The present study showed that prenatal PCB126 exposure had dose-related adverse effects on spermatogenesis in aging rats and may have accelerated spermatogenic senescence. Because the serum testosterone levels of the PCB126 groups and the vehicle group were similar, a direct endocrine cause for the observed effects was unlikely. 

Share article

Recommended Articles

Argyria
Tin Yan Lee, M.B., C...
Argyria, silver toxicity, skin pigmentation, systemic exposure, dermatopathology, toxicology

Background:An 84-year-old man with benign prostatic hyperplasia was admitted for acute kidney injury... 2 weeks ago

APOL1 Kidney Disease Variants — Information fro...
Simone Sanna-Cherchi...
APOL1, chronic kidney disease, focal segmental glomerulosclerosis, West Africa, genetic variants, Trypanosoma brucei, genotype, ethnolinguistic groups

Background:Chronic kidney disease (CKD) disproportionately affects populations of African ancestry, ... 2 weeks ago

APOL1 Bi- and Monoallelic Variants and Chronic Kid...
R.A. Gbadegesin, I. ...
APOL1, chronic kidney disease, West Africans, genetic variants, focal segmental glomerulosclerosis, case-control study

Background: Apolipoprotein L1 gene (APOL1) variants are risk factors for chronic kidney disease (CKD... 2 weeks ago

A Randomized Trial of Drug Route in Out-of-Hospit...
K. Couper, C. Ji, C....
out-of-hospital cardiac arrest, intraosseous, intravenous, vascular access, epinephrine, randomized trial, survival, neurologic outcome

Background: In patients with out-of-hospital cardiac arrest, the effectiveness of drugs such as epin... 2 weeks ago

A Comparison of Peripherally Inserted Central Cath...
Amanda J. Ullman, De...
peripherally inserted central catheter, PICC, hydrophobic, chlorhexidine, polyurethane, device failure, infectious complications, thrombotic complications, randomized controlled trial

BACKGROUNDNew catheter materials for peripherally inserted central catheters (PICCs) may reduce the ... 2 weeks ago

Case 4-2025: A 41-Year-Old Man with Syncope, Ankle...
Daniel Restrepo, Sad...
Löfgren’s syndrome, Sarcoidosis, Bilateral hilar lymphadenopathy, Erythema nodosum, Inflammatory arthritis, Syncope, Glucocorticoids, Cardiac sarcoidosis, Pulmonary nodules, Autoimmune disease.

A 41-year-old man with a history of coronary artery disease presented with syncope, bilateral ankle ... 2 weeks ago

Case 2-2025: A 21-Year-Old Man with Loss of Consci...
Eric F. Shappell, Br...
Posterior reversible encephalopathy syndrome, Sickle cell disease, Seizure, Vaso-occlusive crisis, Cerebral fat embolism, MRI, Red-cell exchange, Hypertension, Microhemorrhages, Neurologic complications.

A 21-year-old man with sickle cell disease presented with loss of consciousness and a fall, followed... 2 weeks ago

Case 1-2025: A 35-Year-Old Woman with Shortness of...
Jessica S. Tangren, ...
Focal segmental glomerulosclerosis, Nephrotic syndrome, Postpartum complications, Preeclampsia, Proteinuria, Hypoalbuminemia, Kidney biopsy, Hypertension, Edema, Glomerular disease, Immunosuppression, Collapsing glomerulopathy.

A 35-year-old woman presented with postpartum shortness of breath and progressive leg edema. Initial... 2 weeks ago

What’s Next for Nicotine? The Coming Legal and P...
Patricia J. Zettler ...
Nicotine reduction, FDA regulation, tobacco control, addiction, public health policy, legal challenges

BACKGROUNDOn January 16, 2025, the FDA proposed limiting nicotine levels in cigarettes to 0.70 mg pe... 2 weeks ago

The Definition of Heart Failure
Jason Gurney
Heart failure, terminology, patient experience, stigma, chronic disease, renaming

BACKGROUNDHeart failure is a major public health problem, affecting more than 64 million people (1 t... 2 weeks ago

BPROAD — End of the Road for Debate on Systoli...
Shuchi Anand, M.D., ...
Systolic blood pressure, type 2 diabetes, hypertension, cardiovascular risk, intensive therapy, ACCORD BP, SPRINT trial

BACKGROUNDElevated blood pressure mediates much of the organ toxicity affecting persons with type 2 ... 2 weeks ago

Sotatercept in Patients with Pulmonary Arterial Hy...
Marc Humbert et al. ...
Sotatercept, pulmonary arterial hypertension, WHO functional class, REVEAL Lite 2, composite endpoint, hospitalization, mortality

BACKGROUNDSotatercept improves exercise capacity and delays the time to clinical worsening in patien... 2 weeks ago

Severe HDL Cholesterol Reduction with Bempedoic A...
Francesco Sbrana et ...
HDL cholesterol, bempedoic acid, fenofibrate, drug interaction, familial hypercholesterolemia, stomatocytes

A low plasma level of high-density lipoprotein (HDL) cholesterol is a strong, independent predict... 2 weeks ago

Routine Cerebral Embolic Protection during Transc...
Rajesh K. Kharbanda ...
TAVI, cerebral embolic protection, stroke, randomized trial, aortic stenosis, CEP device

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral... 2 weeks ago

Pulsed Field or Cryoballoon Ablation for Paroxys...
Tobias Reichlin et a...
pulsed field ablation, cryoballoon ablation, paroxysmal atrial fibrillation, pulmonary-vein isolation, nonthermal ablation, implantable cardiac monitor, arrhythmia recurrence, catheter ablation, randomized trial, SINGLE SHOT CHAMPION trial

Background: Pulmonary-vein isolation is effective for paroxysmal atrial fibrillation (AF). Pulsed fi... 2 weeks ago

Oral Semaglutide and Cardiovascular Outcomes in H...
D.K. McGuire et al. ...
oral semaglutide, type 2 diabetes, cardiovascular outcomes, GLP-1 receptor agonist, MACE, atherosclerotic cardiovascular disease, chronic kidney disease, myocardial infarction, randomized controlled trial, SOUL trial

Background:The cardiovascular safety of oral semaglutide, a glucagon-like peptide-1 (GLP-1) recep... 2 weeks ago

Modest Blood Pressure Increase with Age in Adults...
Andrea Kelly et al.
Down’s syndrome, blood pressure, hypertension, systolic blood pressure, diastolic blood pressure, pulse pressure, cardiovascular phenotype, aging, BMI, sympathetic activity

Background: In the general population, blood pressure typically rises with age, but this pattern in ... 2 weeks ago

Medium- and Distal-Vessel Occlusion — The Limit ...
J. Mocco, M.D
thrombectomy, stroke, medium-vessel occlusion, distal-vessel occlusion, ESCAPE-MeVO trial, DISTAL trial, ischemic stroke, endovascular therapy, mortality, intracranial hemorrhage

Background: Thrombectomy for stroke has shown significant benefits in large-vessel occlusions, but i... 2 weeks ago

Lorundrostat Efficacy and Safety in Patients with...
L.J. Laffin et al. f...
lorundrostat, hypertension, aldosterone synthase inhibitor, randomized controlled trial, ambulatory blood pressure, hyperkalemia, treatment-resistant hypertension, eGFR, mineralocorticoid, cardiovascular risk

Background: Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone sy... 2 weeks ago

Lepodisiran — A Long-Duration Small Interfering ...
Steven E. Nissen, We...
Lepodisiran, lipoprotein(a), siRNA therapy, cardiovascular disease, RNA interference, ALPACA trial, LDL cholesterol, atherosclerosis, PCSK9 inhibitors, Eli Lilly.

"BACKGROUNDElevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular... 2 weeks ago

Records : 20 of 2150 | Page : of 108 | Limit